News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ovarian Cancer Vaccine Made From Tumors Yields Responses, University of Pennsylvania Study


4/9/2013 7:27:01 AM

Scientists have crafted an experimental vaccine against advanced ovarian cancer that was safe and triggered an immune response using muscled-up blood cells primed by tumors that were taken from the patients. It took 7 days to make the injection individually for each woman, according to a report today at the American Association for Cancer Research meeting in Washington. The therapeutic vaccine was the first step in a two-part process that involved teaching the woman’s blood cells to recognize the cancer, then infusing an army of her own infection-fighting immune system cells to attack the tumor. The study was the first clinical trial of this new approach.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES